非过敏症专科医生对青霉素过敏去标签化的最新进展及未来的叙述性综述。
Narrative review of recent developments and the future of penicillin allergy de-labelling by non-allergists.
作者信息
Powell Neil, Blank Michael, Luintel Akish, Elkhalifa Shuayb, Bhogal Rashmeet, Wilcock Michael, Wakefield Michael, Sandoe Jonathan
机构信息
Pharmacy Department, Royal Cornwall Hospital Trust, Truro, Cornwall, UK.
Imperial College Healthcare NHS Trust, London, UK.
出版信息
NPJ Antimicrob Resist. 2024 Jul 10;2(1):18. doi: 10.1038/s44259-024-00035-6.
Abstract
This article outlines recent developments in non-allergist delivered penicillin allergy de-labelling (PADL), discusses remaining controversies and uncertainties and explores the future for non-allergist delivered PADL. Recent developments include national guidelines for non-allergist delivered PADL and validation of penicillin allergy risk assessment tools. Controversies remain on which penicillin allergy features are low risk of genuine allergy. In the future genetic or immunological tests may facilitate PADL.
摘要
本文概述了非过敏专科医生进行青霉素过敏重新评估（PADL）的最新进展，讨论了尚存的争议和不确定性，并探讨了非过敏专科医生进行PADL的未来发展。最新进展包括非过敏专科医生进行PADL的国家指南以及青霉素过敏风险评估工具的验证。关于哪些青霉素过敏特征真正过敏风险较低仍存在争议。未来，基因或免疫检测可能会促进PADL的发展。
相似文献
1
Narrative review of recent developments and the future of penicillin allergy de-labelling by non-allergists.非过敏症专科医生对青霉素过敏去标签化的最新进展及未来的叙述性综述。
NPJ Antimicrob Resist. 2024 Jul 10;2(1):18. doi: 10.1038/s44259-024-00035-6.
2
Penicillin allergy de-labelling by non-allergists: a comparison of testing protocols.非过敏症专科医生对青霉素过敏标签的去除：检测方案比较
JAC Antimicrob Resist. 2023 Dec 19;5(6):dlad134. doi: 10.1093/jacamr/dlad134. eCollection 2023 Dec.
3
Non-allergist healthcare workers views on delivering a penicillin allergy de-labelling inpatient pathway: identifying the barriers and enablers.非过敏症专科医护人员对实施青霉素过敏重新认定住院患者流程的看法：识别障碍与促进因素
JAC Antimicrob Resist. 2024 Feb 7;6(1):dlae014. doi: 10.1093/jacamr/dlae014. eCollection 2024 Feb.
4
Experiences of an inpatient penicillin allergy de-labelling pathway: capturing the patient voice.住院患者青霉素过敏标签去除流程的经验：倾听患者声音
JAC Antimicrob Resist. 2024 Feb 9;6(1):dlae020. doi: 10.1093/jacamr/dlae020. eCollection 2024 Feb.
5
Removal of incorrect penicillin allergy labels in a UK hospital.在英国一家医院去除错误的青霉素过敏标签。
Clin Microbiol Infect. 2023 Oct;29(10):1338.e1-1338.e4. doi: 10.1016/j.cmi.2023.06.024. Epub 2023 Jun 22.
6
Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2).前瞻性、多中心、过敏专科医生与非过敏专科医生在低风险青霉素过敏脱标签治疗中的头对头比较：有效性、安全性和生活质量（HK-DADI2）。
J Allergy Clin Immunol Pract. 2024 Jul;12(7):1801-1808.e2. doi: 10.1016/j.jaip.2024.04.010. Epub 2024 Apr 16.
7
Penicillin allergy management strategies relevant for clinical practice - a narrative review.与临床实践相关的青霉素过敏管理策略——一项叙述性综述
Rom J Intern Med. 2025 Mar 31;63(1):28-38. doi: 10.2478/rjim-2024-0035. eCollection 2025 Mar 1.
8
A pharmacist-led penicillin allergy de-labelling project within a preoperative assessment clinic: the low-hanging fruit is within reach.药剂师主导的术前评估门诊青霉素过敏去标签项目：低挂的果实触手可及。
J Hosp Infect. 2023 Sep;139:1-5. doi: 10.1016/j.jhin.2023.06.012. Epub 2023 Jun 19.
9
An Economic Evaluation of Direct Oral Penicillin Challenge for De-Labelling Low Risk Patients With a Penicillin Allergy Label.对青霉素过敏标签的低风险患者进行脱标签直接口服青霉素激发试验的经济学评估。
Clin Exp Allergy. 2025 May;55(5):378-390. doi: 10.1111/cea.14633. Epub 2025 Feb 5.
10
Reliability and validation of an electronic penicillin allergy risk-assessment tool in a pregnant population.电子青霉素过敏风险评估工具在孕妇群体中的可靠性与有效性验证
Allergy Asthma Clin Immunol. 2024 Oct 19;20(1):55. doi: 10.1186/s13223-024-00918-3.
引用本文的文献
1
Towards standardized skin testing for drug-induced allergic reactions.迈向药物性过敏反应的标准化皮肤试验。
Saudi Pharm J. 2025 Jul 9;33(4):26. doi: 10.1007/s44446-025-00031-5.
2
Fighting Antibiotic Resistance: Insights Into Human Barriers and New Opportunities: Antibiotic Resistance Constantly Rises With the Development of Human Activities. We discuss Barriers and Opportunities to Get It Under Control.对抗抗生素耐药性：对人类障碍和新机遇的洞察：随着人类活动的发展，抗生素耐药性持续上升。我们探讨控制抗生素耐药性的障碍与机遇。
Bioessays. 2025 Jun;47(6):e70001. doi: 10.1002/bies.70001. Epub 2025 Mar 27.
本文引用的文献
1
Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2).前瞻性、多中心、过敏专科医生与非过敏专科医生在低风险青霉素过敏脱标签治疗中的头对头比较：有效性、安全性和生活质量（HK-DADI2）。
J Allergy Clin Immunol Pract. 2024 Jul;12(7):1801-1808.e2. doi: 10.1016/j.jaip.2024.04.010. Epub 2024 Apr 16.
2
A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling 'low risk' patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systems.一项多中心观察性研究，旨在调查非过敏专业医护人员通过直接口服青霉素挑战来解除“低危”青霉素过敏患者标签（SPACE 研究）的可行性：对医疗保健系统的影响。
J Infect. 2024 Mar;88(3):106116. doi: 10.1016/j.jinf.2024.01.015. Epub 2024 Feb 6.
3
Non-allergist healthcare workers views on delivering a penicillin allergy de-labelling inpatient pathway: identifying the barriers and enablers.非过敏症专科医护人员对实施青霉素过敏重新认定住院患者流程的看法：识别障碍与促进因素
JAC Antimicrob Resist. 2024 Feb 7;6(1):dlae014. doi: 10.1093/jacamr/dlae014. eCollection 2024 Feb.
4
Penicillin allergy de-labelling by non-allergists: a comparison of testing protocols.非过敏症专科医生对青霉素过敏标签的去除：检测方案比较
JAC Antimicrob Resist. 2023 Dec 19;5(6):dlad134. doi: 10.1093/jacamr/dlad134. eCollection 2023 Dec.
5
Management of BAME patients with a history of penicillin allergy: barriers to best practice and strategies to overcome these.有青霉素过敏史的黑人和少数族裔患者的管理：最佳实践的障碍及克服这些障碍的策略。
Infect Prev Pract. 2023 Nov 14;5(4):100319. doi: 10.1016/j.infpip.2023.100319. eCollection 2023 Dec.
6
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches.低风险青霉素过敏脱敏：直接口服激发试验实践、实施及多学科方法的范围综述
Expert Rev Anti Infect Ther. 2024 Jan-Jun;22(1-3):59-69. doi: 10.1080/14787210.2023.2296068. Epub 2024 Feb 12.
7
APAAACI clinical pathway on direct provocation testing for penicillin allergy delabeling.美国变态反应、哮喘与免疫学会临床实践指南：青霉素过敏标签去除的直接激发试验
Asia Pac Allergy. 2023 Dec;13(4):142-147. doi: 10.5415/apallergy.0000000000000122. Epub 2023 Oct 18.
8
Artificial intelligence-enabled penicillin allergy delabelling: an implementation study.人工智能辅助青霉素过敏去标签化：一项实施研究。
Intern Med J. 2023 Nov;53(11):2119-2122. doi: 10.1111/imj.16266.
9
"Let a sleeping dog lie": Perspectives from patients and clinicians about penicillin allergy delabeling.“别惹麻烦”：患者和临床医生对青霉素过敏标签去除的看法。
Ann Allergy Asthma Immunol. 2024 Jan;132(1):95-97. doi: 10.1016/j.anai.2023.10.014. Epub 2023 Oct 17.
10
Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.住院和门诊环境中青霉素过敏去标签化的障碍：一项定性研究
Allergy Asthma Clin Immunol. 2023 Oct 11;19(1):88. doi: 10.1186/s13223-023-00842-y.
Zotero 插件